You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Microsatellite Stable

Showing 1 - 25 of 4,797
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite

Completed
  • Metastatic Colorectal Adenocarcinoma
  • regorafenib plus anti-PD-1 antibodies
  • Changsha, Hunan, China
    Hunan Cancer hospital
Jul 4, 2023

CCR5, Microsatellite Stable, Metastatic Trial (700mg leronlimab weekly dose, 80mg Regorafenib at week 1, 120mg Regorafenib at

Withdrawn
  • CCR5
  • +3 more
  • 700mg leronlimab weekly dose
  • +3 more
  • (no location specified)
Feb 15, 2023

Advanced Colorectal Adenocarcinoma, Advanced Microsatellite Stable Colorectal Carcinoma, Metastatic Colorectal Adenocarcinoma

Not yet recruiting
  • Advanced Colorectal Adenocarcinoma
  • +5 more
  • Balstilimab
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jan 3, 2023

Microsatellite Stable Metastatic Colorectal Cancer Trial in Tucson, Aurora, New Brunswick (ALX148, Cetuximab, Pembrolizumab)

Recruiting
  • Microsatellite Stable Metastatic Colorectal Cancer
  • Tucson, Arizona
  • +2 more
Jul 28, 2022

Metastatic Cancer, Endometrium Cancer, Endometrial Carcinoma Trial in Houston (Futibatinib, Pembrolizumab)

Recruiting
  • Metastatic Cancer
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 31, 2022

Colorectal Cancer Trial (KN046, regorafenib)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Aug 2, 2023

Colorectal Liver Metastases Trial in Nanjing (Radiation: High- and Low-dose radiotherapy, PD-1 Inhibitors)

Recruiting
  • Colorectal Liver Metastases
  • Radiation: High- and Low-dose radiotherapy
  • PD-1 Inhibitors
  • Nanjing, Jiangsu, China
    Jiangsu Cancer Hospital
Sep 13, 2023

Colorectal Cancer, Microsatellite Stable Colorectal Carcinoma Trial in Shanghai (Vitamin E, Fruquintinib, Tislelizumab)

Not yet recruiting
  • Colorectal Cancer
  • Microsatellite Stable Colorectal Carcinoma
  • Vitamin E
  • +2 more
  • Shanghai, Shanghai, China
    270 Dongan Road, Fudan University Shanghai Cancer Center
Mar 5, 2023

Colonic Tumors, Neoadjuvant Therapy, Immune Checkpoint Inhibitors Trial in Nanning (Tislelizumab, Oxaliplatin, Capecitabine)

Recruiting
  • Colonic Neoplasms
  • +2 more
  • Nanning, Guangxi, China
    The First Affiliated Hospital of Guangxi Medical University
Nov 9, 2023

Microsatellite Stable (MSS) Colorectal Adenocarcinomas, Colorectal Adenocarcinoma Trial in Baltimore (Nivolumab, Relatlimab)

Recruiting
  • Microsatellite Stable (MSS) Colorectal Adenocarcinomas
  • Colorectal Adenocarcinoma
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Mar 14, 2022

Anal Squamous Cell Carcinoma, Colorectal Tumors, Soft Tissue Sarcoma Trial (Regorafenib in combination with Tislelizumab)

Not yet recruiting
  • Anal Squamous Cell Carcinoma
  • +7 more
  • Regorafenib in combination with Tislelizumab
  • (no location specified)
Oct 12, 2022

Gastric Cancer, Pancreatic Cancer Trial in Fukuoka-shi (Phase I part, Phase II part)

Recruiting
  • Gastric Cancer
  • Pancreatic Cancer
  • Phase I part
  • Phase II part
  • Fukuoka-shi, Fukuoka, Fukuoka, Japan
    Kyushu University Hospital
Jun 24, 2022

Metastatic Colorectal Cancer, MSS Trial in Heidelberg (Pembrolizumab, Maraviroc)

Completed
Has Results
  • Metastatic Colorectal Cancer
  • MSS
  • Heidelberg, Germany
    National Center for Tumor Diseases, University Hospital Heidelbe
May 17, 2022

Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma

Terminated
  • Metastatic Colon Adenocarcinoma
  • +27 more
  • San Francisco, California
  • +1 more
Jan 5, 2023

Metastatic Microsatellite-stable Colorectal Cancer Trial (LB-100, Atezolizumab)

Not yet recruiting
  • Metastatic Microsatellite-stable Colorectal Cancer
  • (no location specified)
Sep 1, 2023

Colorectal Cancer Trial (all trans Retinoic Acid, Atezolizumab, Bevacizumab)

Not yet recruiting
  • Colorectal Cancer
  • all trans Retinoic Acid
  • +2 more
  • (no location specified)
Aug 11, 2023

Metastatic Microsatellite-stable Colorectal Cancer Trial in China (Experimental drug, Control Rx)

Recruiting
  • Metastatic Microsatellite-stable Colorectal Cancer
  • Experimental drug
  • Control Rx
  • Hefei, Anhui, China
  • +11 more
Mar 13, 2023

Microsatellite Stable Metastatic Colorectal Cancer Trial in Shanghai (Regorafenib, Toripalimab, High/low-dose radiotherapy)

Recruiting
  • Microsatellite Stable Metastatic Colorectal Cancer
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 19, 2023

Locally Advanced Rectal Cancer Trial in Guangzhou (AK104, Capecitabine, Neoadjuvant Radiotherapy)

Not yet recruiting
  • Locally Advanced Rectal Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 5, 2023

Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Boston (Nivolumab, Ipilimumab, Radiation)

Active, not recruiting
  • Pancreatic Cancer
  • Metastatic Pancreatic Cancer
  • Boston, Massachusetts
  • +2 more
Sep 7, 2022

Metastatic Colorectal Cancer Trial in Milan (Temozolomide, Nivolumab, Ipilimumab)

Completed
  • Metastatic Colorectal Cancer
  • Milan, MI, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Apr 1, 2022

Metastatic Colorectal Cancer Trial in Milan (Bevacizumab, Irinotecan, Leucovorin)

Recruiting
  • Metastatic Colorectal Cancer
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Apr 1, 2022

Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer Trial in Australia, China

Recruiting
  • Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer
  • Benowa, Queensland, Australia
  • +7 more
Jan 30, 2023

New Patient Stratification Tools in MSS RAS mt mCRC

Completed
  • Advanced Colorectal Cancer
    • Heidelberg, Germany
    • +9 more
    Nov 25, 2022

    Rectal Cancer, Locally Advanced Trial (radiation, drug, procedure)

    Not yet recruiting
    • Rectal Cancer
    • Locally Advanced
    • Short-course radiotherapy
    • +3 more
    • (no location specified)
    Oct 8, 2022